MONTREAL, QUEBEC--(MARKET WIRE)--May 10, 2006 -- Ambrilia Biopharma Inc. (TSX:AMB.TO - News), a biopharmaceutical company developing innovative therapeutics in the fields of cancer and infectious diseases, announced today its first quarter 2006 results and provided an update on progress and anticipated milestones for its product portfolio.
